Global Breast Cancer Liquid Biopsy Market Research Report 2023

Report ID: 1983407 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Circulating Tumor Cells (CTCs)
        1.2.3 Cell-Free DNA (CfDNA)
        1.2.4 Extracellular Vesicles (EVs)
        1.2.5 Other Circulating Biomarkers
    1.3 Market by Application
        1.3.1 Global Breast Cancer Liquid Biopsy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Diagnostic Centers
        1.3.4 Laboratories
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Breast Cancer Liquid Biopsy Market Perspective (2017-2028)
    2.2 Breast Cancer Liquid Biopsy Growth Trends by Region
        2.2.1 Breast Cancer Liquid Biopsy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Breast Cancer Liquid Biopsy Historic Market Size by Region (2017-2022)
        2.2.3 Breast Cancer Liquid Biopsy Forecasted Market Size by Region (2023-2028)
    2.3 Breast Cancer Liquid Biopsy Market Dynamics
        2.3.1 Breast Cancer Liquid Biopsy Industry Trends
        2.3.2 Breast Cancer Liquid Biopsy Market Drivers
        2.3.3 Breast Cancer Liquid Biopsy Market Challenges
        2.3.4 Breast Cancer Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue
        3.1.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue (2017-2022)
        3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2017-2022)
    3.2 Global Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Breast Cancer Liquid Biopsy Revenue
    3.4 Global Breast Cancer Liquid Biopsy Market Concentration Ratio
        3.4.1 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Liquid Biopsy Revenue in 2021
    3.5 Breast Cancer Liquid Biopsy Key Players Head office and Area Served
    3.6 Key Players Breast Cancer Liquid Biopsy Product Solution and Service
    3.7 Date of Enter into Breast Cancer Liquid Biopsy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Liquid Biopsy Breakdown Data by Type
    4.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Type (2017-2022)
    4.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2023-2028)
5 Breast Cancer Liquid Biopsy Breakdown Data by Application
    5.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Application (2017-2022)
    5.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Breast Cancer Liquid Biopsy Market Size (2017-2028)
    6.2 North America Breast Cancer Liquid Biopsy Market Size by Country (2017-2022)
    6.3 North America Breast Cancer Liquid Biopsy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Breast Cancer Liquid Biopsy Market Size (2017-2028)
    7.2 Europe Breast Cancer Liquid Biopsy Market Size by Country (2017-2022)
    7.3 Europe Breast Cancer Liquid Biopsy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size (2017-2028)
    8.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Breast Cancer Liquid Biopsy Market Size (2017-2028)
    9.2 Latin America Breast Cancer Liquid Biopsy Market Size by Country (2017-2022)
    9.3 Latin America Breast Cancer Liquid Biopsy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size (2017-2028)
    10.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 QIAGEN
        11.1.1 QIAGEN Company Detail
        11.1.2 QIAGEN Business Overview
        11.1.3 QIAGEN Breast Cancer Liquid Biopsy Introduction
        11.1.4 QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.1.5 QIAGEN Recent Development
    11.2 Roche Diagnostics
        11.2.1 Roche Diagnostics Company Detail
        11.2.2 Roche Diagnostics Business Overview
        11.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Introduction
        11.2.4 Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.2.5 Roche Diagnostics Recent Development
    11.3 Bio-Rad Laboratories
        11.3.1 Bio-Rad Laboratories Company Detail
        11.3.2 Bio-Rad Laboratories Business Overview
        11.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Introduction
        11.3.4 Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.3.5 Bio-Rad Laboratories Recent Development
    11.4 Myriad Genetics
        11.4.1 Myriad Genetics Company Detail
        11.4.2 Myriad Genetics Business Overview
        11.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Introduction
        11.4.4 Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.4.5 Myriad Genetics Recent Development
    11.5 Menarini Silicon Biosystems
        11.5.1 Menarini Silicon Biosystems Company Detail
        11.5.2 Menarini Silicon Biosystems Business Overview
        11.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Introduction
        11.5.4 Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.5.5 Menarini Silicon Biosystems Recent Development
    11.6 Genomic Health
        11.6.1 Genomic Health Company Detail
        11.6.2 Genomic Health Business Overview
        11.6.3 Genomic Health Breast Cancer Liquid Biopsy Introduction
        11.6.4 Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.6.5 Genomic Health Recent Development
    11.7 Thermo Fisher Scientific
        11.7.1 Thermo Fisher Scientific Company Detail
        11.7.2 Thermo Fisher Scientific Business Overview
        11.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Introduction
        11.7.4 Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.7.5 Thermo Fisher Scientific Recent Development
    11.8 Illumina
        11.8.1 Illumina Company Detail
        11.8.2 Illumina Business Overview
        11.8.3 Illumina Breast Cancer Liquid Biopsy Introduction
        11.8.4 Illumina Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.8.5 Illumina Recent Development
    11.9 Biocept
        11.9.1 Biocept Company Detail
        11.9.2 Biocept Business Overview
        11.9.3 Biocept Breast Cancer Liquid Biopsy Introduction
        11.9.4 Biocept Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.9.5 Biocept Recent Development
    11.10 Trovagene
        11.10.1 Trovagene Company Detail
        11.10.2 Trovagene Business Overview
        11.10.3 Trovagene Breast Cancer Liquid Biopsy Introduction
        11.10.4 Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.10.5 Trovagene Recent Development
    11.11 Guardant Health
        11.11.1 Guardant Health Company Detail
        11.11.2 Guardant Health Business Overview
        11.11.3 Guardant Health Breast Cancer Liquid Biopsy Introduction
        11.11.4 Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.11.5 Guardant Health Recent Development
    11.12 RainDance Technologies
        11.12.1 RainDance Technologies Company Detail
        11.12.2 RainDance Technologies Business Overview
        11.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Introduction
        11.12.4 RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.12.5 RainDance Technologies Recent Development
    11.13 MDx Health
        11.13.1 MDx Health Company Detail
        11.13.2 MDx Health Business Overview
        11.13.3 MDx Health Breast Cancer Liquid Biopsy Introduction
        11.13.4 MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.13.5 MDx Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Circulating Tumor Cells (CTCs)
    Table 3. Key Players of Cell-Free DNA (CfDNA)
    Table 4. Key Players of Extracellular Vesicles (EVs)
    Table 5. Key Players of Other Circulating Biomarkers
    Table 6. Global Breast Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Breast Cancer Liquid Biopsy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Breast Cancer Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Breast Cancer Liquid Biopsy Market Share by Region (2017-2022)
    Table 10. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Breast Cancer Liquid Biopsy Market Share by Region (2023-2028)
    Table 12. Breast Cancer Liquid Biopsy Market Trends
    Table 13. Breast Cancer Liquid Biopsy Market Drivers
    Table 14. Breast Cancer Liquid Biopsy Market Challenges
    Table 15. Breast Cancer Liquid Biopsy Market Restraints
    Table 16. Global Breast Cancer Liquid Biopsy Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Breast Cancer Liquid Biopsy Market Share by Players (2017-2022)
    Table 18. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Liquid Biopsy as of 2021)
    Table 19. Ranking of Global Top Breast Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Breast Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Breast Cancer Liquid Biopsy Product Solution and Service
    Table 23. Date of Enter into Breast Cancer Liquid Biopsy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Breast Cancer Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2017-2022)
    Table 27. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2023-2028)
    Table 29. Global Breast Cancer Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2017-2022)
    Table 31. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2023-2028)
    Table 33. North America Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. QIAGEN Company Detail
    Table 44. QIAGEN Business Overview
    Table 45. QIAGEN Breast Cancer Liquid Biopsy Product
    Table 46. QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 47. QIAGEN Recent Development
    Table 48. Roche Diagnostics Company Detail
    Table 49. Roche Diagnostics Business Overview
    Table 50. Roche Diagnostics Breast Cancer Liquid Biopsy Product
    Table 51. Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 52. Roche Diagnostics Recent Development
    Table 53. Bio-Rad Laboratories Company Detail
    Table 54. Bio-Rad Laboratories Business Overview
    Table 55. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product
    Table 56. Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 57. Bio-Rad Laboratories Recent Development
    Table 58. Myriad Genetics Company Detail
    Table 59. Myriad Genetics Business Overview
    Table 60. Myriad Genetics Breast Cancer Liquid Biopsy Product
    Table 61. Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 62. Myriad Genetics Recent Development
    Table 63. Menarini Silicon Biosystems Company Detail
    Table 64. Menarini Silicon Biosystems Business Overview
    Table 65. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product
    Table 66. Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 67. Menarini Silicon Biosystems Recent Development
    Table 68. Genomic Health Company Detail
    Table 69. Genomic Health Business Overview
    Table 70. Genomic Health Breast Cancer Liquid Biopsy Product
    Table 71. Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 72. Genomic Health Recent Development
    Table 73. Thermo Fisher Scientific Company Detail
    Table 74. Thermo Fisher Scientific Business Overview
    Table 75. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product
    Table 76. Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 77. Thermo Fisher Scientific Recent Development
    Table 78. Illumina Company Detail
    Table 79. Illumina Business Overview
    Table 80. Illumina Breast Cancer Liquid Biopsy Product
    Table 81. Illumina Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 82. Illumina Recent Development
    Table 83. Biocept Company Detail
    Table 84. Biocept Business Overview
    Table 85. Biocept Breast Cancer Liquid Biopsy Product
    Table 86. Biocept Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 87. Biocept Recent Development
    Table 88. Trovagene Company Detail
    Table 89. Trovagene Business Overview
    Table 90. Trovagene Breast Cancer Liquid Biopsy Product
    Table 91. Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 92. Trovagene Recent Development
    Table 93. Guardant Health Company Detail
    Table 94. Guardant Health Business Overview
    Table 95. Guardant Health Breast Cancer Liquid BiopsyProduct
    Table 96. Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 97. Guardant Health Recent Development
    Table 98. RainDance Technologies Company Detail
    Table 99. RainDance Technologies Business Overview
    Table 100. RainDance Technologies Breast Cancer Liquid BiopsyProduct
    Table 101. RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 102. RainDance Technologies Recent Development
    Table 103. MDx Health Company Detail
    Table 104. MDx Health Business Overview
    Table 105. MDx Health Breast Cancer Liquid BiopsyProduct
    Table 106. MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 107. MDx Health Recent Development
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Breast Cancer Liquid Biopsy Market Share by Type: 2021 VS 2028
    Figure 2. Circulating Tumor Cells (CTCs) Features
    Figure 3. Cell-Free DNA (CfDNA) Features
    Figure 4. Extracellular Vesicles (EVs) Features
    Figure 5. Other Circulating Biomarkers Features
    Figure 6. Global Breast Cancer Liquid Biopsy Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Diagnostic Centers Case Studies
    Figure 9. Laboratories Case Studies
    Figure 10. Breast Cancer Liquid Biopsy Report Years Considered
    Figure 11. Global Breast Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Breast Cancer Liquid Biopsy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Breast Cancer Liquid Biopsy Market Share by Region: 2021 VS 2028
    Figure 14. Global Breast Cancer Liquid Biopsy Market Share by Players in 2021
    Figure 15. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Liquid Biopsy as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Breast Cancer Liquid Biopsy Revenue in 2021
    Figure 17. North America Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Breast Cancer Liquid Biopsy Market Share by Country (2017-2028)
    Figure 19. United States Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Breast Cancer Liquid Biopsy Market Share by Country (2017-2028)
    Figure 23. Germany Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Region (2017-2028)
    Figure 31. China Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Breast Cancer Liquid Biopsy Market Share by Country (2017-2028)
    Figure 39. Mexico Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Country (2017-2028)
    Figure 43. Turkey Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. QIAGEN Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 46. Roche Diagnostics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 47. Bio-Rad Laboratories Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 48. Myriad Genetics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 49. Menarini Silicon Biosystems Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 50. Genomic Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 52. Illumina Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 53. Biocept Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 54. Trovagene Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 55. Guardant Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 56. RainDance Technologies Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 57. MDx Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
QIAGEN
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini Silicon Biosystems
Genomic Health
Thermo Fisher Scientific
Illumina
Biocept
Trovagene
Guardant Health
RainDance Technologies
MDx Health
Frequently Asked Questions
Breast Cancer Liquid Biopsy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Breast Cancer Liquid Biopsy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Breast Cancer Liquid Biopsy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Veterinary Endoscopy

Veterinary Endoscopy market is segmented by players, region (country), by Type and by Application ... Read More

Latex Allergy

Latex Allergy market is segmented by players, region (country), by Type and by Application. Playe ... Read More